30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Allos Therapeutics Inc (ALTH)

Track

Stock chart
Ticker: ALTH Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SPECTRUM PHARMACEUTICALS INC
1 purchase — total 238,155,809 USD
Buy 5 Sep 2012
Value US$4,477,800.65 | Price 475.70 | Shares 57,126
Planned sale 1 Mar 2012
Value US$3,779,525.65 | Price 198.88 | Shares 8,268
Planned sale 29 Feb 2012
Value US$4,622.88 | Price 1.53 | Shares 3,031
Planned sale 24 Feb 2012
Value US$2,277.10 | Price 1.55 | Shares 1,469
Planned sale 24 Feb 2011
Value US$4,700.80 | Price 3.20 | Shares 1,469
Planned sale 10 May 2010
Value US$21,684.46 | Price 7.03 | Shares 3,085
Planned sale 12 Apr 2010
Value US$643,530.00 | Price 8.58 | Shares 75,000
Planned sale 10 Mar 2010
Value US$155,612.00 | Price 7.78 | Shares 20,000
Planned sale 5 Mar 2010
Value US$70,196.00 | Price 7.02 | Shares 10,000
Planned sale 4 Mar 2010
Value US$81,300.74 | Price 6.98 | Shares 11,640
Planned sale 1 Mar 2010
Value US$304,875.00 | Price 8.13 | Shares 37,500
Planned sale 1 Mar 2010
Value US$325,204.00 | Price 8.13 | Shares 40,000
Planned sale 24 Feb 2010
Value US$55,765.68 | Price 7.57 | Shares 7,362
Planned sale 24 Feb 2010
Value US$17,476.56 | Price 7.44 | Shares 2,349
Planned sale 23 Feb 2010
Value US$32,331.22 | Price 7.51 | Shares 4,304
Planned sale 23 Feb 2010
Value US$44,378.05 | Price 7.44 | Shares 5,968
Planned sale 23 Feb 2010
Value US$10,634.16 | Price 7.51 | Shares 1,416
Planned sale 23 Feb 2010
Value US$11,024.68 | Price 7.51 | Shares 1,468
Planned sale 11 Jan 2010
Value US$331,737.97 | Price 7.30 | Shares 45,428
Planned sale 8 Jan 2010
Value US$322,918.42 | Price 7.11 | Shares 45,429
Planned sale 7 Jan 2010
Value US$307,113.67 | Price 6.76 | Shares 45,429
Planned sale 6 Jan 2010
Value US$308,163.08 | Price 6.78 | Shares 45,429
Planned sale 5 Jan 2010
Value US$301,496.55 | Price 6.64 | Shares 45,428
Planned sale 4 Jan 2010
Value US$166,220.29 | Price 6.54 | Shares 25,428
Planned sale 10 Aug 2009
Value US$694,302.00 | Price 8.13 | Shares 85,400
Planned sale 10 Aug 2009
Value US$2,819,311.20 | Price 8.24 | Shares 342,000
Planned sale 5 Aug 2009
Value US$65,150.40 | Price 8.14 | Shares 8,000
Planned sale 5 Aug 2009
Value US$118,754.94 | Price 8.13 | Shares 14,600
Planned sale 3 Aug 2009
Value US$400,000.00 | Price 8.00 | Shares 50,000
Planned sale 3 Aug 2009
Value US$389,480.00 | Price 7.79 | Shares 50,000
Planned sale 26 Mar 2009
Value US$291,205.85 | Price 7.37 | Shares 39,500
Planned sale 25 Mar 2009
Value US$49,208.73 | Price 7.13 | Shares 6,900
Planned sale 16 Mar 2009
Value US$25,674.48 | Price 7.13 | Shares 3,600
Planned sale 13 Mar 2009
Value US$35,189.00 | Price 7.00 | Shares 5,027
Planned sale 13 Mar 2009
Value US$41,048.00 | Price 7.00 | Shares 5,864
Planned sale 12 Mar 2009
Value US$455,811.58 | Price 7.02 | Shares 64,973
Planned sale 12 Mar 2009
Value US$356,500.00 | Price 7.13 | Shares 50,000
Planned sale 12 Mar 2009
Value US$485,009.78 | Price 7.02 | Shares 69,136
Sale 6 Feb 2009
Value US$181.64 | Price 8.26 | Shares 22
Sale 6 Feb 2009
Value US$203,176.15 | Price 8.17 | Shares 24,857
Sale 6 Feb 2009
Value US$8.26 | Price 8.26 | Shares 1
Sale 6 Feb 2009
Value US$5,762.53 | Price 8.17 | Shares 705
Sale 6 Feb 2009
Value US$1,940.21 | Price 8.26 | Shares 235
Sale 6 Feb 2009
Value US$2,152,259.63 | Price 8.17 | Shares 263,312
Sale 6 Feb 2009
Value US$1,732.85 | Price 8.17 | Shares 212
Sale 6 Feb 2009
Value US$66.05 | Price 8.26 | Shares 8
Sale 6 Feb 2009
Value US$76,670.24 | Price 8.17 | Shares 9,380
Sale 6 Feb 2009
Value US$5,531.65 | Price 8.26 | Shares 670
Sale 6 Feb 2009
Value US$6,142,888.61 | Price 8.17 | Shares 751,534
Sale 5 Feb 2009
Value US$38,299.43 | Price 8.11 | Shares 4,725
Sale 5 Feb 2009
Value US$9,805.56 | Price 8.17 | Shares 1,200
Sale 5 Feb 2009
Value US$52,179.81 | Price 8.16 | Shares 6,392
Sale 5 Feb 2009
Value US$1,086.16 | Price 8.11 | Shares 134
Sale 5 Feb 2009
Value US$277.82 | Price 8.17 | Shares 34
Sale 5 Feb 2009
Value US$1,477.56 | Price 8.16 | Shares 181
Sale 5 Feb 2009
Value US$405,617.33 | Price 8.11 | Shares 50,041
Sale 5 Feb 2009
Value US$103,881.74 | Price 8.17 | Shares 12,713
Sale 5 Feb 2009
Value US$552,728.88 | Price 8.16 | Shares 67,709
Sale 5 Feb 2009
Value US$324.23 | Price 8.11 | Shares 40
Sale 5 Feb 2009
Value US$81.71 | Price 8.17 | Shares 10
Sale 5 Feb 2009
Value US$448.98 | Price 8.16 | Shares 55
Sale 5 Feb 2009
Value US$14,444.36 | Price 8.11 | Shares 1,782
Sale 5 Feb 2009
Value US$3,701.60 | Price 8.17 | Shares 453
Sale 5 Feb 2009
Value US$19,681.72 | Price 8.16 | Shares 2,411
Sale 5 Feb 2009
Value US$1,157,712.81 | Price 8.11 | Shares 142,827
Sale 5 Feb 2009
Value US$296,503.79 | Price 8.17 | Shares 36,286
Sale 5 Feb 2009
Value US$1,577,574.05 | Price 8.16 | Shares 193,252
Sale 4 Feb 2009
Value US$205,191.21 | Price 8.46 | Shares 24,256
Sale 4 Feb 2009
Value US$21,961.15 | Price 8.47 | Shares 2,593
Sale 4 Feb 2009
Value US$2,429.66 | Price 9.03 | Shares 269
Sale 4 Feb 2009
Value US$5,820.07 | Price 8.46 | Shares 688
Sale 4 Feb 2009
Value US$626.74 | Price 8.47 | Shares 74
Sale 4 Feb 2009
Value US$72.26 | Price 9.03 | Shares 8
Sale 4 Feb 2009
Value US$2,173,524.40 | Price 8.46 | Shares 256,936
Sale 4 Feb 2009
Value US$232,781.46 | Price 8.47 | Shares 27,485
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2012-09-06 2012-09-05 B Purchase SPECTRUM PHARMACEUTICALS INC Large shareholder
57,126 +34.3%
475.70
US$4,477,801 		57,126 +34.3% 475.70 US$4,477,801
2012-03-01 2012-03-01 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
8,268 -11.5%
198.88
US$3,779,526 		8,268 -11.5% 198.88 US$3,779,526
2012-03-01 2012-02-29 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
41,087 +32.2%
75.81
US$4,606,948 		41,087 +32.2% 75.81 US$4,606,948
2012-02-27 2012-02-24 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,469 -1.3%
1.55
US$2,277 		1,469 -1.3% 1.55 US$2,277
2011-02-25 2011-02-24 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,469 -1.5%
3.20
US$4,701 		1,469 -1.5% 3.20 US$4,701
2010-05-12 2010-05-10 PlS Planned sale Clark David C

VP, Finance

Officer
3,085 -15.3%
7.03
US$21,684 		3,085 -15.3% 7.03 US$21,684
2010-04-14 2010-04-12 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
75,000 -56.4%
8.58
US$643,530 		75,000 -56.4% 8.58 US$643,530
2010-03-12 2010-03-10 PlS Planned sale Clark David C

VP, Finance

Officer
20,000 -50.8%
7.78
US$155,612 		20,000 -50.8% 7.78 US$155,612
2010-03-08 2010-03-05 PlS Planned sale Clark David C

VP, Finance

Officer
10,000 -34.1%
7.02
US$70,196 		10,000 -34.1% 7.02 US$70,196
2010-03-08 2010-03-04 PlS Planned sale Clark David C

VP, Finance

Officer
11,640 -37.6%
6.98
US$81,301 		11,640 -37.6% 6.98 US$81,301
2010-03-03 2010-03-01 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
37,500 -26.6%
8.13
US$304,875 		37,500 -26.6% 8.13 US$304,875
2010-03-03 2010-03-01 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
40,000 -22.1%
8.13
US$325,204 		40,000 -22.1% 8.13 US$325,204
2010-02-24 2010-02-24 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
7,362 -3.2%
7.57
US$55,766 		7,362 -3.2% 7.57 US$55,766
2010-02-24 2010-02-24 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
2,349 -3.9%
7.44
US$17,477 		2,349 -3.9% 7.44 US$17,477
2010-02-24 2010-02-23 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
4,304 -1.8%
7.51
US$32,331 		4,304 -1.8% 7.51 US$32,331
2010-02-24 2010-02-23 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
5,968 -4.1%
7.44
US$44,378 		5,968 -4.1% 7.44 US$44,378
2010-02-24 2010-02-23 PlS Planned sale Graboyes Marc H

SVP, General Counsel

Officer
1,416 -2.3%
7.51
US$10,634 		1,416 -2.3% 7.51 US$10,634
2010-02-24 2010-02-23 PlS Planned sale BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Officer
1,468 -6.0%
7.51
US$11,025 		1,468 -6.0% 7.51 US$11,025
2010-01-11 2010-01-11 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,428 -8.7%
7.30
US$331,738 		45,428 -8.7% 7.30 US$331,738
2010-01-11 2010-01-08 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
7.11
US$322,918 		45,429 -8.7% 7.11 US$322,918
2010-01-11 2010-01-07 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
6.76
US$307,114 		45,429 -8.7% 6.76 US$307,114
2010-01-06 2010-01-06 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,429 -8.7%
6.78
US$308,163 		45,429 -8.7% 6.78 US$308,163
2010-01-06 2010-01-05 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
45,428 -8.7%
6.64
US$301,497 		45,428 -8.7% 6.64 US$301,497
2010-01-06 2010-01-04 PlS Planned sale HOFFMAN STEPHEN J Non-Executive Director
25,428 -5.1%
6.54
US$166,220 		25,428 -5.1% 6.54 US$166,220
2009-08-12 2009-08-10 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
85,400 -49.0%
8.13
US$694,302 		85,400 -49.0% 8.13 US$694,302
2009-08-12 2009-08-10 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
342,000 -59.6%
8.24
US$2,819,311 		342,000 -59.6% 8.24 US$2,819,311
2009-08-07 2009-08-05 PlS Planned sale BERNS PAUL L

Chief Executive Officer

Officer
8,000 -3.3%
8.14
US$65,150 		8,000 -3.3% 8.14 US$65,150
2009-08-05 2009-08-05 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
14,600 -14.1%
8.13
US$118,755 		14,600 -14.1% 8.13 US$118,755
2009-08-05 2009-08-03 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
50,000 -71.4%
8.00
US$400,000 		50,000 -71.4% 8.00 US$400,000
2009-08-05 2009-08-03 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
50,000 -36.0%
7.79
US$389,480 		50,000 -36.0% 7.79 US$389,480
2009-03-27 2009-03-26 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
39,500 -25.3%
7.37
US$291,206 		39,500 -25.3% 7.37 US$291,206
2009-03-27 2009-03-25 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
6,900 -5.6%
7.13
US$49,209 		6,900 -5.6% 7.13 US$49,209
2009-03-16 2009-03-16 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
3,600 -3.0%
7.13
US$25,674 		3,600 -3.0% 7.13 US$25,674
2009-03-16 2009-03-13 PlS Planned sale Clark David C

VP, Finance

Officer
5,027 -41.3%
7.00
US$35,189 		5,027 -41.3% 7.00 US$35,189
2009-03-16 2009-03-13 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
5,864 -22.6%
7.00
US$41,048 		5,864 -22.6% 7.00 US$41,048
2009-03-16 2009-03-12 PlS Planned sale Clark David C

VP, Finance

Officer
64,973 -90.1%
7.02
US$455,812 		64,973 -90.1% 7.02 US$455,812
2009-03-16 2009-03-12 PlS Planned sale CARUSO JAMES V

Chief Commercial Officer

Officer
50,000 -30.1%
7.13
US$356,500 		50,000 -30.1% 7.13 US$356,500
2009-03-16 2009-03-12 PlS Planned sale Graboyes Marc H

VP, General Counsel

Officer
69,136 -77.5%
7.02
US$485,010 		69,136 -77.5% 7.02 US$485,010
2009-02-06 2009-02-06 S Sale 14159 capital (GP), LLC Large shareholder
22 -0.0%
8.26
US$182 		22 -0.0% 8.26 US$182
2009-02-06 2009-02-06 S Sale 14159 capital (GP), LLC Large shareholder
24,857 -11.5%
8.17
US$203,176 		24,857 -11.5% 8.17 US$203,176
2009-02-06 2009-02-06 S Sale BAKER JULIAN Large shareholder
1 -0.0%
8.26
US$8 		1 -0.0% 8.26 US$8
2009-02-06 2009-02-06 S Sale BAKER JULIAN Large shareholder
705 -11.5%
8.17
US$5,763 		705 -11.5% 8.17 US$5,763
2009-02-06 2009-02-06 S Sale Baker Biotech Capital (GP), LLC Large shareholder
235 -0.0%
8.26
US$1,940 		235 -0.0% 8.26 US$1,940
2009-02-06 2009-02-06 S Sale Baker Biotech Capital (GP), LLC Large shareholder
263,312 -11.5%
8.17
US$2,152,260 		263,312 -11.5% 8.17 US$2,152,260
2009-02-06 2009-02-06 S Sale Baker Bros. Capital (GP), LLC Large shareholder
212 -11.5%
8.17
US$1,733 		212 -11.5% 8.17 US$1,733
2009-02-06 2009-02-06 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
8 -0.0%
8.26
US$66 		8 -0.0% 8.26 US$66
2009-02-06 2009-02-06 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
9,380 -11.5%
8.17
US$76,670 		9,380 -11.5% 8.17 US$76,670
2009-02-06 2009-02-06 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
670 -0.0%
8.26
US$5,532 		670 -0.0% 8.26 US$5,532
2009-02-06 2009-02-06 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
751,534 -11.5%
8.17
US$6,142,889 		751,534 -11.5% 8.17 US$6,142,889
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
4,725 -2.1%
8.11
US$38,299 		4,725 -2.1% 8.11 US$38,299
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
1,200 -0.5%
8.17
US$9,806 		1,200 -0.5% 8.17 US$9,806
2009-02-06 2009-02-05 S Sale 14159 capital (GP), LLC Large shareholder
6,392 -2.8%
8.16
US$52,180 		6,392 -2.8% 8.16 US$52,180
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
134 -2.1%
8.11
US$1,086 		134 -2.1% 8.11 US$1,086
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
34 -0.5%
8.17
US$278 		34 -0.5% 8.17 US$278
2009-02-06 2009-02-05 S Sale BAKER JULIAN Large shareholder
181 -2.8%
8.16
US$1,478 		181 -2.8% 8.16 US$1,478
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
50,041 -2.1%
8.11
US$405,617 		50,041 -2.1% 8.11 US$405,617
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
12,713 -0.5%
8.17
US$103,882 		12,713 -0.5% 8.17 US$103,882
2009-02-06 2009-02-05 S Sale Baker Biotech Capital (GP), LLC Large shareholder
67,709 -2.8%
8.16
US$552,729 		67,709 -2.8% 8.16 US$552,729
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
40 -2.1%
8.11
US$324 		40 -2.1% 8.11 US$324
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
10 -0.5%
8.17
US$82 		10 -0.5% 8.17 US$82
2009-02-06 2009-02-05 S Sale Baker Bros. Capital (GP), LLC Large shareholder
55 -2.8%
8.16
US$449 		55 -2.8% 8.16 US$449
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
1,782 -2.1%
8.11
US$14,444 		1,782 -2.1% 8.11 US$14,444
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
453 -0.5%
8.17
US$3,702 		453 -0.5% 8.17 US$3,702
2009-02-06 2009-02-05 S Sale Baker / Tisch Capital (GP), LLC Large shareholder
2,411 -2.8%
8.16
US$19,682 		2,411 -2.8% 8.16 US$19,682
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
142,827 -2.1%
8.11
US$1,157,713 		142,827 -2.1% 8.11 US$1,157,713
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
36,286 -0.5%
8.17
US$296,504 		36,286 -0.5% 8.17 US$296,504
2009-02-06 2009-02-05 S Sale Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
193,252 -2.8%
8.16
US$1,577,574 		193,252 -2.8% 8.16 US$1,577,574
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
24,256 -9.6%
8.46
US$205,191 		24,256 -9.6% 8.46 US$205,191
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
2,593 -1.0%
8.47
US$21,961 		2,593 -1.0% 8.47 US$21,961
2009-02-06 2009-02-04 S Sale 14159 capital (GP), LLC Large shareholder
269 -0.1%
9.03
US$2,430 		269 -0.1% 9.03 US$2,430
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
688 -9.6%
8.46
US$5,820 		688 -9.6% 8.46 US$5,820
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
74 -1.0%
8.47
US$627 		74 -1.0% 8.47 US$627
2009-02-06 2009-02-04 S Sale BAKER JULIAN Large shareholder
8 -0.1%
9.03
US$72 		8 -0.1% 9.03 US$72
2009-02-06 2009-02-04 S Sale Baker Biotech Capital (GP), LLC Large shareholder
256,936 -9.6%
8.46
US$2,173,524 		256,936 -9.6% 8.46 US$2,173,524
2009-02-06 2009-02-04 S Sale Baker Biotech Capital (GP), LLC Large shareholder
27,485 -1.1%
8.47
US$232,781 		27,485 -1.1% 8.47 US$232,781
Explore more

More insider trading research around Allos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America